Interferon γ limits the effectiveness of melanoma peptide vaccines
- Hyun Il Cho,
- Young Ran Lee,
- Esteban Celis(corresponding author)
- University of South Florida
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
The development of effective therapeutic vaccines to generate tumor-reactive cytotoxic T lymphocytes (CTLs) continues to be a top research priority. However, in spite of some promising results, there are no clear examples of vaccines that eradicate established tumors. Most vaccines are ineffective because they generate low numbers of CTLs and because numerous immunosuppressive factors abound in tumor-bearing hosts. We designed a peptide vaccine that produces large numbers of tumor-reactive CTLs in a mouse model of melanoma. Surprisingly, CTL tumor recognition and antitumor effects decreased in the presence of interferon γ (IFNγ), a cytokine that can provide therapeutic benefit. Tumors exposed to IFNγ evade CTLs by inducing large amounts of noncognate major histocompatibility complex class I molecules, which limit T-cell activation and effector function. Our results demonstrate that peptide vaccines can eradicate large, established tumors in circumstances under which the inhibitory activities of IFNγ are curtailed.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 135-144 (10 pages)Journal (Volume, Issue Number)
Blood (Volume 117, Issue 1)Publication milestones
- Published - 01/06/2011
Publication status
ISSN
0006-4971Publication IDs
- Scopus: 78650983452
- PubMed: 20889921
